Forte Biosciences
FBRX
24 hedge funds and large institutions have $4.12M invested in Forte Biosciences in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 11 closing their positions.
48.36% more ownership
Funds ownership: 2.09% → 50.45% (+48%)
27% less funds holding
Funds holding: 33 → 24 (-9)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
60% less capital invested
Capital invested by funds: $10.2M → $4.12M (-$6.12M)
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$121K |
| 2 |
FAM
Fred Alger Management
New York
|
+$94K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.52K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$359K |
| 2 |
Renaissance Technologies
New York
|
-$71.6K |
| 3 |
Two Sigma Investments
New York
|
-$21.9K |
| 4 |
State Street
Boston,
Massachusetts
|
-$20.2K |
| 5 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
-$15.8K |
FBRX Hedge Fund Activity: Q3 2024 in Review
24 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q3 2024, worth a combined $4.12M — down 60% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of FBRX and 2 opened new positions — a net loss of 9 holders — while 12 trimmed existing stakes and 7 added.
The largest buyer was Susquehanna International Group, adding an estimated $121K. The largest seller was Perceptive Advisors, cutting an estimated $359K.
- 24 institutional investors held Forte Biosciences (FBRX) as of Q3 2024, down from 33 in Q2 2024.
- Funds reported $4.12M of Forte Biosciences stock for Q3 2024, down 60% quarter-over-quarter.
- 2 funds opened new Forte Biosciences positions in Q3 2024 and 11 closed out, a net change of -9 holders.
- The largest Forte Biosciences buyer in Q3 2024 was Susquehanna International Group, an estimated $121K added.
- The largest Forte Biosciences seller in Q3 2024 was Perceptive Advisors, an estimated $359K sold.
Based on aggregated 13F filings for Q3 2024.